Naoya Hayashi1,2, Junichi Hata2,3, Tetsu Yoshida2, Yawara Haga1,2, Hideyuki Okano2,4, Hirotaka James Okano3, and Akira Furukawa1
1Department of Radiological Sciences, Human Health Sciences, Tokyo Metropolitan University Graduate School, Tokyo, Japan, 2Laboratory for Marmoset Neural Architecture, Center for Brain Science, RIKEN, Saitama, Japan, 3Division of Regenerative Medicine, The Jikei University School of Medicine, Tokyo, Japan, 4Department of Physiology, Keio University School of Medicine, Tokyo, Japan
Synopsis
We
examined which gene we should transduce for genetic reporter for Magnetic Resonance
Imaging (MRI) by comparing T1 or T2 values of the cells followed by exposure to
MnCl2 or Holo-transferrin. We identified the cell which has the
shortest T1 or T2 values and it indicates that they can be useful genetic
reporter for T1 Weighted Imaging (T1WI) or T2 Weighted Imaging (T2WI).
Introduction
Currently, we can label cells by
transducing some specific genes. These are called genetic reporters. For
example, green fluorescence protein (GFP) is commonly used for labeling cells
by fluorescent proteins. We can also observe reporter signals of the luciferin-luciferase
system from outside of the living animals with IVIS. However, its resolution is
not high. Therefore, in this study, we examined a new genetic reporter, which allows
observation of the labeled cells in living animals with MRI. Therefore, we
transduced a group of DNAs that can draw and maintain metal ions to cells,
added metal ions, and measured their T1 or T2 values.Methods
This study was conducted in cultured 293T cells (Fig. 1), which is
derived from human fetus kidney. 293T cells were cultured in 6-well plates and
the number of cells was 6×105 when they were seeded to 6-well
plates. The plasmids were CAG-FLAG-transferrin receptor, CAG-FLAG-DMT1,
CAG-FLAG-Ferritin, CAG-FLAG-FerritinM6A, CAG-FLAG-Mms6, and CAG-Venus. We
transduced some combinations of these plasmids to 293T cells. The method of transfection
was lipofection with a Lipofectamine 3000®︎ Transfection Kit. One
day after transfection, we exposed 293T cells to MnCl2 or
Holo-transferrin. One hour (MnCl2) or 3 hours (Holo-transferrin)
later 1,2, we collected the cells and put them in PCR tubes with 20 ul phosphate-buffered saline
(PBS; Fig. 2). Then we measured T1 or T2 values with a 9.4 T MRI scanner
(BioSpec 94/30; Bruker Biospin, Ettlingen, Germany). A MRI scan was performed
with the following parameters: T1 measurement: rapid acquisition with relaxation
enhancement (RARE); repetition time (TR), 500 - 20247 ms (12 steps); echo time
(ET), 9.8 ms; resolution, 0.1×0.1×1.0 mm; T2 measurement, multi-slice multi-echo
(MSME); repetition time (TR), 6000 ms; ET, 10 – 1500 ms (150 steps); and resolution,
0.1×0.1×1.0 mm. Results
When
we exposed cells to Holo-transferrin, FerritinM6A shortened T2 values the most,
compared to exposure to Ferritin, FerritinM6A, and Mms6 (Fig. 3-b), which have
the ability to maintain Fe ions 2-5. The T2 value of FerritinM6A was
smaller than transferrin receptor (TfR) + DMT1 + FerritinM6A (Fig. 3-c). The T2
value of FerritinM6A only was -36% in comparison to controls (GFP; Fig. 3-d).
When
we exposed cells to MnCl2, FerritinM6A shortened T1 values the most
among Ferritin, FerritinM6A, and Mms6 as well as Holo-transferrin (Fig. 4-b).
Then the T1 value of TfR + DMT1 + FerritinM6A was the smallest among some
combinations of TfR, DMT1, and FerritinM6A (Fig. 4-c). The T1 value of TfR +
DMT1 + FerritinM6A was -13% in comparison to controls (Fig. 4-d).Discussion
The
result that the T2 value of FerritinM6A was shorter than that of Ferritin
agrees with a previous study 2. On the other hand, the previous study also suggested
that the T2 value of FerritinM6A was three quarters of Ferritin 2. In
our study, the difference between TfR + DMT1 + FerritinM6A and TfR + DMT1 + Ferritin
was not very large. Here, transferrin receptor and DMT1 are reported as proteins
involved in taking Fe ions 6-8. In contrast, the T2 value of TfR + DMT1
+ FerritinM6A was higher than FerritinM6A, which might obstruct T2 shortening
by FerritinM6A (Fig 1-c). This is the likely reason why the T2 value of
FerritinM6A was not different from that of Ferritin. Finally, FerritinM6A only
had the smallest T2 value. Therefore, it was shown that FerritinM6A only is the
best genetic reporter for MRI imaging in T2WI.
Next,
when we exposed cells to MnCl2, the result that FerritinM6A
shortened T1 values the best among Ferritin, FerritinM6A and Mms6 was the same
as for Holo-transferrin (Fig 2-b). Then the combination of transferrin receptor
and DMT1 was better than FerritinM6A only (Fig 2-c). In a previous study, it was
reported that DMT1 has the ability of shortening T1values 9. Our
result was in agreement. In addition, the differences in their T1 values seemed
large. However, we cannot say that FerritinM6A did not play a role in T1
shortening because the T1 value of the combination of three genes (transferrin receptor
+ DMT1 + FerritinM6A) was the smallest. Therefore, we can say that their
combination is the best genetic reporter for MRI imaging in T1WI.
However, some limitations should be noted. 293T
cells are from human fetus kidneys and we transduced DNA from them. Therefore,
when we transduce the DNA to cells in living animals, such as mice, it is
unknown whether we can get the same T1 or T2 shortening effect. It is true that
the combination of genes we found in this study is the best, but there is still
no confirmation that it can make a very strong contrast.Conclusion
We
showed that FerritinM6A is the best genetic reporter for T2WI and that the
combination of transferrin receptor, DMT1, and FerritinM6A is the best for
T1WI.
In
the future, we will transduce the DNAs that we specified in this study to
analyze mice and T1WI or T2WI.Acknowledgements
This
research is partially supported by the program for Brain Mapping by Integrated
Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for
Medical Research and development, AMED.
Conflict
of Interest (COI) of the Principal Presenter:No
potential COI to disclose.
References
1.
Lewis CM, Graves SA, Hernandez R, et al. 52Mn Production for PET/MRI Tracking
Of Human Stem Cells Expressing Divalent Metal Transporter 1 (DMT1).
Theranostics. 2015;5(3): 227-239.
2.
Radoul M, Lewin L, Cohen B, et al. Genetic manipulation of iron
biomineralization enhances MR relaxivity in a ferritin-M6A chimeric complex.
Sci Rep. 2016;6:26550
3.
Rouault TA. Iron metabolism in the CNS: implications for neurodegenerative diseases.
Nat Rev Neurosci. 2013;14:551-564.
4.
Lohsse A, Borg S, Raschdorf O, et al. Genetic dissection of the mamAB and mms6
operons reveals a gene set essential for magnetosome biogenesis in
Magnetospirillum gryphiswaldense. J Bacteriol. 2014;196(14):2658-2669.
5.
Elfick A, Rischitor G, Mouras R, et al. Biosynthesis of magnetic nanoparticles
by human mesenchymal stem cells following transfection with the magnetotactic
bacterial gene mms6. Sci Rep. 2017;7:39755
6. Li Y, Jiao Q, Xu H, et al. Biometal
Dyshomeostasis and Toxic Metal Accumulations in the Development of Alzheimer’s
Disease. Front Mol Neurosci. 2017;10:339
7. Moos T, Morgan EH, et al. Transferrin
and transferrin receptor function in brain barrier systems. Cell Mol Neurobiol.
2000;20(1):77-95.
8. Wolff NA, Garrick MD, Zhao L, et al. A
role for divalent metal transporter (DMT1) in mitochondrial uptake of iron and
manganese. Sci Rep. 2018;8(1):211.
9. Bartelle BB, Szulc KU, Suero-Abreu GA,
et al. Divalent Metal Transporter, DMT1: A Novel MRI Reporter Protein. Magn
Reson Med. 2013;70(3):842–850.